Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

DPT Laboratories And Bradley Pharmaceuticals Solidify Partnership

By Pharmaceutical Processing | January 20, 2005

DPT Laboratories, Ltd. and its affiliate DPT Lakewood Inc. recently announced that it reached agreement with Bradley Pharmaceuticals, Inc. to continue a manufacturing agreement for Zonalon&#153, a topical dermatological preparation, and other products. DPT had been manufacturing Zonalon for Bioglan Pharmaceuticals Company, who was acquired by Bradley on August 10, 2004. Bradley acquired all rights in Zonalon as part of the acquisition and this agreement is to assure a seamless continuation of the manufacturing business.

In addition, Bradley announced that Bradley and DPT were ending all pending litigation between the companies in New Jersey and Texas, which arose out of disputes concerning patents and trade secrets. “Bradley’s past litigation against DPT, and our public statements concerning it, were based on a good faith analysis of the information available to us when we started that case”, states Daniel Glassman, Bradley’s President and CEO. “Our information turned out to be incorrect, and Bradley’s desire to work with DPT on Zonalon testifies to our belief that DPT protects its clients’ confidences and intellectual property, and always has,” said Glassman.

“We are pleased Bradley has publicly acknowledged that their information was incorrect and that DPT takes its clients’ confidentiality very seriously,” says DPT President Paul Johnson. “We will work hard to insure a seamless transition and look forward to a solid future with Bradley,” he adds.

DPT, a DFB Pharmaceuticals, Inc. company, specializes in pharmaceutical development and full service commercial manufacturing of semisolid and liquid, Rx, OTC and biotech products. DPT offerings include semi-solids, liquids, nasal spray, aerosol foam and complex delivery forms, with manufacturing locations in San Antonio, Texas, and Lakewood, New Jersey.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE